Description

(2E,4E,6E,8E,10E,12E,14E)-4,9,13,17,17-Pentamethyl-16,21-Dioxo-2,4,6,8,10,12,14-Docosaheptaenoic Acid is a high-purity, conjugated polyunsaturated fatty acid derivative with a defined all-trans configuration. This compound is valued for its role as a key synthetic intermediate and a potential bioactive molecule in advanced research and development. It is primarily utilized by pharmaceutical R&D teams, specialty chemical manufacturers, and academic researchers working on lipid-based therapeutics, novel drug delivery systems, and complex organic synthesis.

Application

• Pharmaceutical Intermediate: Serves as a critical building block for the synthesis of complex lipid-based drug candidates, retinoid analogs, and specialized pro-resolving mediators.
• Biochemical Research: Used as a reference standard or probe in studies investigating lipid metabolism, cell signaling pathways, and the biological activity of polyunsaturated fatty acid derivatives.
• Specialty Chemical Synthesis: Acts as a precursor for synthesizing advanced materials, specialty surfactants, and functionalized polymers requiring specific olefin geometry.
• Nutraceutical R&D: Investigated for potential applications in the development of high-value nutritional supplements and bioactive ingredients.
• Cosmetic Science: Explored for use in premium skincare formulations targeting specific cellular pathways due to its structural similarity to bioactive lipids.

Basic Information

Product Name	(2E,4E,6E,8E,10E,12E,14E)-4,9,13,17,17-Pentamethyl-16,21-Dioxo-2,4,6,8,10,12,14-Docosaheptaenoic Acid
CAS No.	599-98-4
Molecular Formula	C₂₇H₄₀O₄
Molecular Weight	428.61 g/mol
Synonyms	4,9,13,17,17-Pentamethyl-16,21-dioxo-2,4,6,8,10,12,14-docosaheptaenoic acid; All-trans-Pentamethyl-dioxo-docosaheptaenoic Acid; Conjugated C22:7 Fatty Acid Derivative; PMDDA; (all-E)-4,9,13,17,17-Pentamethyl-16,21-dioxodocosa-2,4,6,8,10,12,14-heptaenoic acid
EINECS	Contact for details

Quality Control

Every batch of our (2E,4E,6E,8E,10E,12E,14E)-4,9,13,17,17-Pentamethyl-16,21-Dioxo-2,4,6,8,10,12,14-Docosaheptaenoic Acid is manufactured under strict quality management systems. We provide comprehensive analytical documentation, including Certificates of Analysis (COA) with data from HPLC, GC, NMR, and mass spectrometry to verify identity, purity, and isomeric composition. Our quality protocols are designed to meet the stringent requirements of pharmaceutical R&D and advanced chemical synthesis.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen or argon) at 2-8°C to minimize oxidation and degradation. For long-term storage, keep the material desiccated at -20°C. The container should be kept in a cool, dry, and well-ventilated area, away from incompatible materials.

Specification

Item	Specification
Appearance	Yellow to orange powder or crystalline solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Isomeric Purity (all-trans)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.